Figure 2
Figure 2. Clinical outcomes of patients with TTP with severe ADAMTS13 deficiency (ADAMTS13 activity <5%) and detectable ADAMTS13 activity (ADAMTS13 activity >5%).

Clinical outcomes of patients with TTP with severe ADAMTS13 deficiency (ADAMTS13 activity <5%) and detectable ADAMTS13 activity (ADAMTS13 activity >5%).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal